About Ion Peptide
Ion Peptide is one of the broadest-catalog peptide research vendors operating in 2026. Their 92-product lineup spans classic research peptides (BPC-157, TB-500, GHK-Cu), GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide), novel buccal delivery strips (B12, NAD+, Glutathione), copper peptide hair and skin topicals, bioregulator peptides (Bronchogen, Cartalax, Cortagen, Pinealon), PDRN products, raw powders, and laboratory consumables. Products ship from domestic facilities with third-party HPLC purity verification on request. Pricing is consistently competitive — particularly on GLP-1 agonists and high-turnover research peptides like BPC-157, TB-500, and GHK-Cu — making them a frequent first-choice for cost-conscious researchers.
Mission
Stock every compound class a peptide researcher needs, price it competitively, test it rigorously, and ship it fast. No vendor lock-in, no inflated margins on popular items, and no artificial scarcity on compounds that should be accessible.
Founder's Story
Ion Peptide was built around a straightforward problem: the peptide research space had too many vendors offering too few products, with pricing that drifted upward precisely because buyers had limited alternatives. The founding team, with backgrounds in analytical chemistry and contract manufacturing, designed the catalog deliberately wide — covering peptides, bioregulators, buccal delivery formats, topicals, and GLP-1 agonists under one roof. The buccal strip line came from direct demand: researchers wanted non-injectable NAD+, B12, and glutathione delivery that sidestepped the reconstitution workflow entirely. The bioregulator range (Bronchogen, Pinealon, Cartalax, Cortagen) followed a gap in Western-market availability of the Khavinson peptide family. The lab supplies and raw powders round out a catalog designed to serve the full research lifecycle.